| 臺大學術典藏 |
2020-03-04T09:03:09Z |
The impact of chronic kidney disease on lipid management and goal attainment in patients with atherosclerosis diseases in Taiwan
|
Lin T.-H.;Chuang S.-Y.;Chu C.-Y.;Lee W.-H.;Hsu P.-C.;Su H.-M.;Li Y.-H.;Fang C.-C.;Wang K.-Y.;Tseng W.-K.;Li A.-H.;Ueng K.-C.;Hsieh I.-C.;Huang L.-C.;Wang C.-H.;Pan W.-H.;Yeh H.-I.;Chau-Chung Wu;Yin W.-H.;Chen J.-W.; Lin T.-H.; Chuang S.-Y.; Chu C.-Y.; Lee W.-H.; Hsu P.-C.; Su H.-M.; Li Y.-H.; Fang C.-C.; Wang K.-Y.; Tseng W.-K.; Li A.-H.; Ueng K.-C.; Hsieh I.-C.; Huang L.-C.; Wang C.-H.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Yin W.-H.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:08Z |
Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan
|
Ho L.-T.; Yin W.-H.; Chuang S.-Y.; Tseng W.-K.; Wu Y.-W.; Hsieh I.-C.; Lin T.-H.; Li Y.-H.; Huang L.-C.; Wang K.-Y.; Ueng K.-C.; Fang C.-C.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:07Z |
Combination with low-dose dextromethorphan improves the effect of amlodipine monotherapy in clinical hypertension a first-in-human, concept-proven, prospective, dose-escalation, multicenter study
|
Yin W.-H.; Chen P.; Yeh H.-I.; Wang K.-Y.; Hung Y.-J.; Tseng W.-K.; Wen M.-S.; Wu T.-C.; CHAU-CHUNG WU; Cheng S.-M.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:07Z |
Guideline-adherent therapy in patients with cardiovascular diseases in Taiwan
|
Jeng J.-S.; Yin W.-H.; Huang C.-C.; Chuang S.-Y.; Yeh H.-I.; Fang C.-C.; Lin T.-H.; Wang K.-Y.; Tseng W.-K.; Huang L.-C.; Ueng K.-C.; Hsieh I.-C.; Li Y.-H.; Pan W.-H.; CHAU-CHUNG WU; Chen J.-W.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-03-04T09:03:06Z |
2017 Taiwan lipid guidelines for high risk patients
|
Li Y.-H.; Ueng K.-C.; Jeng J.-S.; Charng M.-J.; Lin T.-H.; Chien K.-L.; Wang C.-Y.; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W.; CHAU-CHUNG WU; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-04T09:03:06Z |
Identification of new biosignatures for clinical outcomes in stable coronary artery disease - The study protocol and initial observations of a prospective follow-up study in Taiwan
|
Leu H.-B.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:05Z |
Optimal achieved blood pressure for patients with stable coronary artery disease
|
Huang C.-C.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:05Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; Wu Y.-W.; CHAU-CHUNG WU; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-03-04T09:03:05Z |
Association of low serum albumin concentration and adverse cardiovascular events in stable coronary heart disease
|
Chien S.-C.; Chen C.-Y.; Leu H.-B.; Su C.-H.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Yeh H.-I.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:04Z |
Residual risk factors to predict major adverse cardiovascular events in atherosclerotic cardiovascular disease patients with and without diabetes mellitus
|
Lin F.-J.;Tseng W.-K.;Yin W.-H.;Yeh H.-I.;Chen J.-W.;Chau-Chung Wu; Lin F.-J.; Tseng W.-K.; Yin W.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU |
| 臺大學術典藏 |
2020-03-04T09:03:03Z |
The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease
|
Ho S.-K.; Wu Y.-W.; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:03Z |
Erratum: ‘Corrigendum to “2017 Taiwan lipid guidelines for high risk patients” [Journal of the Formosan Medical Association (2017) [217–248]’(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H.; Ueng K.-C.; Jeng J.-S.; Charng M.-J.; Lin T.-H.; Chien K.-L.; Wang C.-Y.; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W.; CHAU-CHUNG WU; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-04T09:03:03Z |
On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study
|
Ho L.-T.; Lin F.-J.; Tseng W.-K.; Yin W.-H.; Wu Y.-W.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU; the Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-03-04T09:03:02Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Li Y.-H.;Chen J.-W.;Lin T.-H.;Wang Y.-C.;Chau-Chung Wu;Yeh H.-I.;Huang C.-C.;Chang K.-C.;Wu C.-K.;Chen P.-W.;Huang C.-W.;Chen Z.-C.;Chang W.-T.;Huang W.-C.;Wang C.-Y.;Lee M.-Y.;Chao A.-C.;Fu W.-R.;Tsai L.-K.;Tang S.-C.;Chan H.-L.;Yang Y.-C.;Wu Y.-W.;Hwang J.-J.;Lin J.-L.; Li Y.-H.; Chen J.-W.; Lin T.-H.; Wang Y.-C.; CHAU-CHUNG WU; Yeh H.-I.; Huang C.-C.; Chang K.-C.; Wu C.-K.; Chen P.-W.; Huang C.-W.; Chen Z.-C.; Chang W.-T.; Huang W.-C.; Wang C.-Y.; Lee M.-Y.; Chao A.-C.; Fu W.-R.; Tsai L.-K.; Tang S.-C.; Chan H.-L.; Yang Y.-C.; Wu Y.-W.; Hwang J.-J.; Lin J.-L. |
| 臺大學術典藏 |
2020-03-04T09:03:02Z |
Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients with Stable Coronary Artery Disease
|
Hsu C.-Y.;Tseng W.-K.;Wu Y.-W.;Lin T.-H.;Yeh H.-I.;Chang K.-C.;Wang J.-H.;Chou R.-H.;Huang C.-Y.;Huang P.-H.;Leu H.-B.;Yin W.-H.;Chau-Chung Wu;Lin S.-J.;Chen J.-W.; Hsu C.-Y.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Chou R.-H.; Huang C.-Y.; Huang P.-H.; Leu H.-B.; Yin W.-H.; CHAU-CHUNG WU; Lin S.-J.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:02Z |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Tsai H.-S.; Tseng W.-K.; Yin W.-H.; Lin F.-J.; Hsuan C.-F.; Wu Y.-W.; Huang L.-C.; Lin T.-H.; Chang K.-C.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU |
| 臺大學術典藏 |
2020-03-04T09:03:00Z |
The benefit of secondary prevention with oat fiber in reducing future cardiovascular event among CAD patients after coronary intervention
|
Leu H.-B.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Chen J.-W.; Wu J.-R.;Leu H.-B.;Yin W.-H.;Tseng W.-K.;Wu Y.-W.;Lin T.-H.;Yeh H.-I.;Chang K.-C.;Wang J.-H.;Chau-Chung Wu;Chen J.-W.; Wu J.-R. |
| 臺大學術典藏 |
2020-03-04T09:03:00Z |
Author Correction: The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease (Scientific Reports, (2018), 8, 1, (14410), 10.1038/s41598-018-32210-x)
|
Ho S.-K.; Wu Y.-W.; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T05:42:45Z |
2017 Taiwan lipid guidelines for high risk patients
|
The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients; Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I |
| 臺大學術典藏 |
2020-03-04T05:42:38Z |
Erratum: ��Corrigendum to ��2017 Taiwan lipid guidelines for high risk patients�� [Journal of the Formosan Medical Association (2017) [217�V248]��(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-04T05:42:36Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Huang C.-C; Chang K.-C; Wu C.-K; Chen P.-W; Huang C.-W; Chen Z.-C; Chang W.-T; Huang W.-C; Wang C.-Y; Lee M.-Y; Chao A.-C; Fu W.-R; Tsai L.-K; SUNG-CHUN TANG; Chan H.-L; Yang Y.-C; Wu Y.-W; Hwang J.-J; Lin J.-L.; Li Y.-H; Chen J.-W; Lin T.-H; Wang Y.-C; Wu C.-C; Yeh H.-I |
| 臺大學術典藏 |
2020-03-04T05:42:32Z |
2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance
|
Chien S.-C; Chen P.-S; Huang Y.-H; SUNG-CHUN TANG; Li Y.-H; Yeh H.-I. |
| 臺大學術典藏 |
2020-03-03T03:06:50Z |
Biofunctionalized magnetic nanoparticles for in vitro labeling and in vivo locating specific biomolecules
|
Wu C.C.; Lin L.Y.; Lin L.C.; Huang H.C.; Yang Y.F.; Liu Y.B.; Tsai M.C.; Gao Y.L.; Wang W.C.; Hung S.W.; Yang S.Y.; Horng H.E.; Yang H.C.; WEN-YIH TSENG; Yeh H.I.; Hsuan C.F.; Lee T.L.; Tseng W.K. |
| 臺大學術典藏 |
2020-03-02T12:10:57Z |
2017 Taiwan lipid guidelines for high risk patients
|
Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-02T12:10:46Z |
Erratum: ��Corrigendum to ��2017 Taiwan lipid guidelines for high risk patients�� [Journal of the Formosan Medical Association (2017) [217�V248]��(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-02T12:10:43Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
SUNG-CHUN TANG;Lin J.-L.;Hwang J.-J;Wu Y.-W;Yang Y.-C;Chan H.-L;Tsai L.-K;Fu W.-R;Chao A.-C;Lee M.-Y;Wang C.-Y;Huang W.-C;Chang W.-T;Chen Z.-C;Huang C.-W;Chen P.-W;Wu C.-K;Chang K.-C;Huang C.-C;Yeh H.-I;Wu C.-C;Wang Y.-C;Lin T.-H;Chen J.-W;Li Y.-H; Li Y.-H; Chen J.-W; Lin T.-H; Wang Y.-C; Wu C.-C; Yeh H.-I; Huang C.-C; Chang K.-C; Wu C.-K; Chen P.-W; Huang C.-W; Chen Z.-C; Chang W.-T; Huang W.-C; Wang C.-Y; Lee M.-Y; Chao A.-C; Fu W.-R; Tsai L.-K; SUNG-CHUN TANG; Chan H.-L; Yang Y.-C; Wu Y.-W; Hwang J.-J; Lin J.-L. |
| 臺大學術典藏 |
2020-03-02T12:10:30Z |
2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance
|
SUNG-CHUN TANG;Yeh H.-I.;Li Y.-H;Huang Y.-H;Chen P.-S;Chien S.-C; Chien S.-C; Chen P.-S; Huang Y.-H; SUNG-CHUN TANG; Li Y.-H; Yeh H.-I. |
| 臺大學術典藏 |
2020-02-27T07:42:46Z |
2015 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension
|
Chiang C.-E.; Wang T.-D.; Ueng K.-C.; Lin T.-H.; Yeh H.-I.; Chen C.-Y.; Wu Y.-J.; Tsai W.-C.; Chao T.-H.; Chen C.-H.; Chu P.-H.; Chao C.-L.; Liu P.-Y.; Sung S.-H.; Cheng H.-M.; Wang K.-L.; Li Y.-H.; Chiang F.-T.; Chen J.-H.; WEN-JONE CHEN; Yeh S.-J.; Lin S.-J.; Lin S.-J.;Yeh S.-J.;WEN-JONE CHEN;Chen J.-H.;Chiang F.-T.;Li Y.-H.;Wang K.-L.;Cheng H.-M.;Sung S.-H.;Liu P.-Y.;Chao C.-L.;Chu P.-H.;Chen C.-H.;Chao T.-H.;Tsai W.-C.;Wu Y.-J.;Chen C.-Y.;Yeh H.-I.;Lin T.-H.;Ueng K.-C.;Wang T.-D.;Chiang C.-E. |
| 臺大學術典藏 |
2020-02-27T07:42:37Z |
The 2017 focused update of the guidelines of the Taiwan society of cardiology (TSOC) and the Taiwan hypertension society (THS) for the management of hypertension
|
Lin J.-L.; Lin J.-L.;Lin S.-J.;Chen M.-F.;Yeh S.-J.;WEN-JONE CHEN;Chen J.-H.;Lai W.-T.;Chiang F.-T.;Wang K.-Y.;Li Y.-H.;Wang K.-L.;Sung S.-H.;Chu P.-H.;Chen C.-Y.;Ueng K.-C.;Shyu K.-G.;Chen C.-H.;Chao T.-H.;Cheng H.-M.;Liu P.-Y.;Yeh H.-I.;Lin T.-H.;Wang T.-D.;Chiang C.-E.; Chiang C.-E.; Wang T.-D.; Lin T.-H.; Yeh H.-I.; Liu P.-Y.; Cheng H.-M.; Chao T.-H.; Chen C.-H.; Shyu K.-G.; Ueng K.-C.; Chen C.-Y.; Chu P.-H.; Sung S.-H.; Wang K.-L.; Li Y.-H.; Wang K.-Y.; Chiang F.-T.; Lai W.-T.; Chen J.-H.; WEN-JONE CHEN; Yeh S.-J.; Chen M.-F.; Lin S.-J. |
| 臺大學術典藏 |
2020-02-25T09:38:31Z |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Tsai, H.-S.;Tseng, W.-K.;Yin, W.-H.;Fang-Ju Lin;Hsuan, C.-F.;Wu, Y.-W.;Huang, L.-C.;Lin, T.-H.;Chang, K.-C.;Li, Y.-H.;Yeh, H.-I.;Chen, J.-W.;Wu, C.-C.; Tsai, H.-S.; Tseng, W.-K.; Yin, W.-H.; FANG-JU LIN; Hsuan, C.-F.; Wu, Y.-W.; Huang, L.-C.; Lin, T.-H.; Chang, K.-C.; Li, Y.-H.; Yeh, H.-I.; Chen, J.-W.; Wu, C.-C. |
| 臺大學術典藏 |
2020-02-25T09:24:04Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh, Y.-T.; Yin, W.-H.; Tseng, W.-K.; FANG-JU LIN; Yeh, H.-I.; Chen, J.-W.; Wu, Y.-W.; Wu, C.-C. |
| 臺大學術典藏 |
2020-02-25T09:10:00Z |
Residual risk factors to predict major adverse cardiovascular events in atherosclerotic cardiovascular disease patients with and without diabetes mellitus
|
FANG-JU LIN; Tseng, W.-K.; Yin, W.-H.; Yeh, H.-I.; Chen, J.-W.; Wu, C.-C. |
| 臺大學術典藏 |
2020-01-13T08:21:29Z |
Dose-related ethanol intake, Cx43 and Nav1.5 remodeling: Exploring insights of altered ventricular conduction and QRS fragmentation in excessive alcohol users
|
Hung, C.-L.; Lai, Y.-J.; Chi, P.-C.; Chen, L.-C.; Tseng, Y.-M.; Kuo, J.-Y.; Lin, C.-I.; Chen, Y.-C.; Lin, S.-J.; Yeh, H.-I.; LIANG-CHIA CHEN |
| 臺大學術典藏 |
2020-01-13T08:21:28Z |
Corrigendum to “Dose-related ethanol intake, Cx43 and Nav1.5 remodeling: Exploring insights of altered ventricular conduction and QRS fragmentation in excessive alcohol users” [J. Mol. Cell. Cardiol. 114 (2018) 150–160](S0022282817303358)(10.1016/j.yjmcc.2017.10.011)
|
Hung, C.-L.; Lai, Y.-J.; Chi, P.-C.; Chen, L.-C.; Tseng, Y.-M.; Kuo, J.-Y.; Lin, C.-I.; Chen, Y.-C.; Lin, S.-J.; Yeh, H.-I.; LIANG-CHIA CHEN |
| 臺大學術典藏 |
2020 |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Wu C.-K.; Chen P.-W.; Huang C.-W.; Chen Z.-C.; Chang W.-T.; Huang W.-C.; CHIH-YUAN WANG; Lee M.-Y.; Chao A.-C.; Fu W.-R.; Tsai L.-K.; Tang S.-C.; Chan H.-L.; Yang Y.-C.; Wu Y.-W.; Hwang J.-J.; Lin J.-L.; Chang K.-C.; Huang C.-C.; Yeh H.-I.; Wu C.-C.; Lin T.-H.; Wang Y.-C.; Chen J.-W.; Li Y.-H.; Li Y.-H.;Chen J.-W.;Lin T.-H.;Wang Y.-C.;Wu C.-C.;Yeh H.-I.;Huang C.-C.;Chang K.-C.;Wu C.-K.;Chen P.-W.;Huang C.-W.;Chen Z.-C.;Chang W.-T.;Huang W.-C.;Chih-Yuan Wang;Lee M.-Y.;Chao A.-C.;Fu W.-R.;Tsai L.-K.;Tang S.-C.;Chan H.-L.;Yang Y.-C.;Wu Y.-W.;Hwang J.-J.;Lin J.-L. |
| 臺大學術典藏 |
2020 |
Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70–100 mg/dL in Taiwan
|
FANG-JU LIN; Shyu K.-G.; Hsieh I.-C.; Huey-Herng Sheu W.; Tu S.-T.; Yeh S.-J.; Chen C.-I.; Lu K.-C.; Wu C.-C.; Shau W.-Y.; Inocencio T.J.; Wen Y.-C.; Yeh H.-I. |
| 國立成功大學 |
2020 |
2020 consensus of taiwan society of cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Chiang, Chiang C.-E.;Ueng, K.-C.;Chao, T.-H.;Lin, T.-H.;Wu, Y.-J.;Wang, K.-L.;Sung, Sung S.-H.;Yeh, H.-I.;Li, Y.-H.;Liu, P.-Y.;Chang, K.-C.;Shyu, K.-G.;Huang, J.-L.;Tsai, C.-D.;Hung, Hung H.-F.;Liu, M.-E.;Chao, T.-F.;Cheng, S.-M.;Cheng, H.-M.;Chu, P.-H.;Yin, W.-H.;Wu, Y.-W.;Chen, W.-J.;Lai, W.-T.;Lin, S.-J.;Yeh, S.-J.;Hwang, J.-J. |
| 國立成功大學 |
2020 |
Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
|
Li, Y.-H.;Tseng, W.-K.;Yin, W.-H.;Lin, F.-J.;Wu, Y.-W.;Hsieh, I.-C.;Lin, T.-H.;Sheu, W.H.-H.;Yeh, H.-I.;Chen, J.-W.;Wu, C.-C.;Investigators, Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry |
| 國立成功大學 |
2020 |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Li, Y.-H.;Chen, J.-W.;Lin, T.-H.;Wang, Y.-C.;Wu, C.-C.;Yeh, H.-I.;Huang, C.-C.;Chang, K.-C.;Wu, C.-K.;Chen, P.-W.;Huang, C.-W.;Chen, Z.-C.;Chang, W.-T.;Huang, W.-C.;Wang, C.-Y.;Lee, M.-Y.;Chao, A.-C.;Fu, W.-R.;Tsai, L.-K.;Tang, S.-C.;Chan, H.-L.;Yang, Yang Y.-C.;Wu, Y.-W.;Hwang, J.-J.;Lin, J.-L. |
| 臺大學術典藏 |
2019-08-27T07:33:21Z |
Membrane proteomics of impaired energetics and cytoskeletal disorganization in elderly diet-induced diabetic mice
|
Lam, C.S.P.;Lee, H.-C.;Liu, C.-Y.;Yeh, H.-I.;Chiau, J.-S.C.;Lai, Y.-J.;Shih, S.-C.;Su, C.-H.;Hsu, Y.-L.;Chang, C.-W.;Han, C.-L.;SZU-HUA PAN;Hung, C.-L.; Hung, C.-L.; SZU-HUA PAN; Han, C.-L.; Chang, C.-W.; Hsu, Y.-L.; Su, C.-H.; Shih, S.-C.; Lai, Y.-J.; Chiau, J.-S.C.; Yeh, H.-I.; Liu, C.-Y.; Lee, H.-C.; Lam, C.S.P. |
| 臺大學術典藏 |
2019-07-09T08:15:05Z |
Erratum: ‘Corrigendum to “2017 Taiwan lipid guidelines for high risk patients” [Journal of the Formosan Medical Association (2017) [217–248]’(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
The Writing Group Of 2017 Taiwan Lipid Guidelines For High Risk Patients;Yeh H.-I.;Wu C.-C.;Chen J.-W.;Yu T.-Y.;Lee C.-C.;Tang S.-C.;Liou C.-W.;Chien S.-C.;Su C.-H.;Liu P.-Y.;Chao T.-H.;Wang C.-Y.;Kuo-Liong Chien;Lin T.-H.;Charng M.-J.;Jeng J.-S.;Ueng K.-C.;Li Y.-H.; Li Y.-H.; Ueng K.-C.; Jeng J.-S.; Charng M.-J.; Lin T.-H.; KUO-LIONG CHIEN; Wang C.-Y.; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W.; Wu C.-C.; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 國立交通大學 |
2019-04-02T05:58:12Z |
Interrelation of transport and optical properties in gold nanoclusters
|
Shu, G. W.; Chen, T. Y.; Shen, J. L.; Lin, C. A. J.; Chang, W. H.; Chan, W. H.; Wang, H. H.; Yeh, H. I.; Chou, W. C. |
| 臺大學術典藏 |
2019 |
Impact of type D personality on clinical outcomes in Asian patients with stable coronary artery disease
|
Leu H.-B.;Yin W.-H.;Tseng W.-K.;Wu Y.-W.;Lin T.-H.;Yeh H.-I.;Cheng Chang K.;Wang J.-H.;Chau-Chung Wu;Chen J.-W.; Leu H.-B.; Yin W.-H.; Chen J.-W.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Cheng Chang K.; Wang J.-H.; CHAU-CHUNG WU |
| 臺大學術典藏 |
2019 |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Wu C.-C.; Chen J.-W.; Lin F.-J.; Hsuan C.-F.; YEN-WEN WU; Huang L.-C.; Lin T.-H.; Chang K.-C.; Li Y.-H.; Yeh H.-I.; Yin W.-H.; Tseng W.-K.; Tsai H.-S. |
| 國立成功大學 |
2019 |
Antithrombotic treatment for symptomatic peripheral artery disease
|
Li, Y.-H.;Yeh, H.-I.;Hwang, J.-J. |
| 國立成功大學 |
2019 |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Tsai, H.-S.;Tseng, W.-K.;Yin, W.-H.;Lin, F.-J.;Hsuan, C.-F.;Wu, Y.-W.;Huang, L.-C.;Lin, T.-H.;Chang, K.-C.;Li, Y.-H.;Yeh, H.-I.;Chen, J.-W.;Wu, C.-C. |
| 臺大學術典藏 |
2018-09-10T18:05:35Z |
2017 Taiwan lipid guidelines for high risk patients
|
Li, Y.-H. ; Ueng, K.-C. ; Jeng, J.-S. ; Charng, M.-J. ; Lin, T.-H. ; Chien, K.-L. ; Wang, C.-Y. ; Chao, T.-H. ; Liu, P.-Y. ; Su, C.-H. ; Chien, S.-C. ; Liou, C.-W. ; Tang, S.-C. ; Lee, C.-C. ; Yu, T.-Y. ; Chen, J.-W. ; Wu, C.-C. ; Yeh, H.-I.; JIANN-SHING JENG; KUO-LIONG CHIEN |
| 臺大學術典藏 |
2018-09-10T15:01:01Z |
Angiotensin receptor blockades effect on peripheral muscular and central aortic arterial stiffness: A meta-analysis of randomized controlled trials and systematic review
|
Yen, C.-H. ; Lai, Y.-H. ; Hung, C.-L. ; Lee, P.-Y. ; Kuo, J.-Y. ; Yeh, H.-I. ; Hou, C.-Y. ; Chien, K.-L.; KUO-LIONG CHIEN |
| 臺大學術典藏 |
2018-09-10T07:05:02Z |
Biofunctionalized magnetic nanoparticles for in vitro labeling and in vivo locating specific biomolecules
|
Wu, C. C.; Lin, L. Y.; Lin, L. C.; Huang, H. C.; Yang, Y. F.; Liu, Y. B.; Tsai, M. C.; Gao, Y. L.; Wang, W. C.; Hung, S. W.; Yang, S. Y.; Horng, H. E.; Yang, H. C.; Tseng, W. Y. I.; Yeh, H. I.; Hsuan, C. F.; Lee, T. L.; Tseng, W. K.; Wu, C.C. and Lin, L.Y. and Lin, L.C. and Huang, H.C. and Yang, Y.F. and Liu, Y.B. and Tsai, M.C. and Gao, Y.L. and Wang, W.C. and Hung, S.W. and Yang, S.Y. and Horng, H.E. and Yang, H.C. and Tseng, W.Y.I. and Yeh, H.I. and Hsuan, C.F. and Lee, T.L. and Tseng, W.K.; WEN-YIH ISAAC TSENG; Wu, C. C.; Lin, L. Y.; Lin, L. C.; Huang, H. C.; Yang, Y. F.; Liu, Y. B.; Tsai, M. C.; Gao, Y. L.; Wang, W. C.; Hung, S. W.; Yang, S. Y.; Horng, H. E.; Yang, H. C.; Hsuan, C. F.; Lee, T. L.; Tseng, W. K. |
| 臺大學術典藏 |
2018-09-10T04:08:10Z |
Cloning, expression, and genomic organization of mouse mp29 gene
|
Chang, M.-S.; Chen, C.-Y.; Yeh, H.-I.; Fan, C.-C.; Huang, C.-J.; Yang, Y.-C.; MAU-SUN CHANG |
